Bionic Sight, Inc.
PrivateLast Round
VC Round
Apr 1, 2025
Est. Valuation
$40M
Company Overview
Bionic Sight, Inc. is a biotechnology company developing optogenetic gene therapies and neuro-prosthetic devices to restore sight to patients with retinal degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B2C
Customer Profile
Revenue Share, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionic Sight, Inc. Comparables
Compare Bionic Sight, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ray Therapeutics | 88% | |
| Nanoscope Therapeutics Inc. | 86% | |
| SparingVision | 83% |
Bionic Sight, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 1, 2025 | ||||
| VC Round | Jan 24, 2017 |
Bionic Sight, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Raptor Group | VC Round |
| Partnership for New York City | VC Round |
| Cornell University Office of University Investments | VC Round |
| Samsara BioCapital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
Raised capital from Partnership Fund for New York City.
- Jan 24, 2017
$2M round led by Beacon Therapeutics.
Bionic Sight, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bionic Sight, Inc.'s valuation, stock price, and market status.
Is Bionic Sight, Inc. a public or private company?
Bionic Sight, Inc. is a private company.
What is the current stock price of Bionic Sight, Inc.?
Bionic Sight, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Bionic Sight, Inc. worth (valuation)?
Bionic Sight, Inc.'s valuation is estimated at $40.0M based on funding round data.
Can I buy Bionic Sight, Inc. stock?
Bionic Sight, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bionic Sight, Inc.'s last funding round?
Bionic Sight, Inc.'s most recent funding round was VC Round on January 24, 2017.
Who are the main investors in Bionic Sight, Inc.?
Key investors in Bionic Sight, Inc. include The Raptor Group, Partnership for New York City, Cornell University, Samsara BioCapital.
Will Bionic Sight, Inc. IPO soon?
No public IPO plans have been announced for Bionic Sight, Inc..
How can I track Bionic Sight, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bionic Sight, Inc.'s secondary market activity and sign up for updates.